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In mammals the pre-gastrula proximal epiblast gives rise to Primordial Germ Cells (PGCs) or 
somatic precursors in response to BMP4 and WNT signaling. Entry into the germline requires 
activation of a naïve-like pluripotency gene regulatory network (GRN). Recent work showed that 
suppression of OTX2 expression in the epiblast by BMP4 allows cells to develop a PGC fate in a 
precise temporal window. However, the mechanisms by which OTX2 suppresses PGC fate are 
unknown. Here we show that OTX2 prevents epiblast cells from activating the pluripotency GRN 
by direct repression of Oct4 and Nanog. Loss of this control during PGC differentiation in vitro 
causes widespread activation of the pluripotency GRN and deregulated response to LIF, BMP4 and 
WNT signaling. These abnormalities, in specific cell culture conditions, result in massive germline 
entry at the expense of somatic mesoderm differentiation. Increased generation of PGCs occurs also 
in mutant embryos. We propose that the OTX2 repressive control of Oct4 and Nanog is at the basis 
of the mechanism determining epiblast contribution to germline and somatic lineage.  
 3
INTRODUCTION  
Primordial Germ Cells (PGCs)  represent the founder cells of the germ cell lineage which ensures 
the transmission of genetic and epigenetic information across the generations (Wylie, 1999; Surani, 
2001; Saitou and Yamaji, 2012; Johnson et al., 2003; Johnson and Alberio, 2015). In mice, both the 
germline and the somatic lineage, the latter referring to embryonic and extraembryonic mesoderm 
(Saitou et al. 2005), originate from the proximal-posterior epiblast of pre-gastrula embryos (Lawson 
et al., 1999; Saitou, 2009). The generation of PGCs is controlled by a precise mechanism 
determining the segregation of the germline from the somatic lineage (Ohinata et al., 2009; Surani 
et al., 2007; Hayashi et al., 2007). The acquisition of PGC identity is associated with loss of somatic 
mesoderm fate (Günesdogan and Surani, 2016; Saitou et al., 2002). In mouse, germline and somatic 
lineage originate in response to BMP and WNT signaling (Lawson et al., 1999; Ohinata et al., 2009; 
Senft et al., 2019). BMP4-mediated activation of the Transcription Factors (TFs) Blimp1 (also 
known as Prdm1), Ap2γ (also known as Tfap2c) and Prdm14 is required for germline entry and 
suppression of somatic mesoderm identity, which is defined by the expression of T (also known as 
Brachyury) and Hoxb1 (Magnúsdóttir et al., 2013; Ohinata et al., 2005; Kurimoto et al., 2008; 
Ancelin et al., 2006; Vincent et al., 2005; Weber et al., 2010;  Yamaji et al., 2008; Nakaki et al., 
2013). Co-expression of Blimp1, Ap2γ, and Prdm14 defines the identity of germ cells in vivo and in 
vitro. Further work indicated that WNT3 is also required for PGC fate (Aramaki et al., 2013). 
Germline entry and development of PGCs also requires the activation of a naïve-like pluripotency 
gene regulatory network (GRN) defined by the TFs Oct4 (also known as Pou5f1), Sox2 and Nanog 
and representing a unique feature of the PGC unipotent state (Saitou and Yamaji, 2012; Hayashi et 
al., 2007; Hackett and Surani, 2014; Leitch et al., 2013; Smith, 2017; Okamura et al., 2008; 
Yamaguchi et al., 2009; Chambers et al., 2007; Zhang and Chambers, 2019; Campolo et al., 2013; 
Kehler et al., 2004; Yeom et al., 1996). Importantly, Nanog activation in epiblast-like cells 
(EpiLCs), a cellular state very similar to pre-gastrulation epiblast (Hayashi et al., 2011; Smith, 
2017), is sufficient for germ cell induction (Murakami et al., 2016) and Oct4 expression in PGCs 
requires a transcriptional regulatory switch from the proximal enhancer (PE) to the distal enhancer 
(DE) (Choi et al., 2016; Wu and Schöler, 2014). The study of germline development has been 
fueled by the realization of a stepwise in vitro culture system generating PGC-like cells (PGCLCs) 
from germline competent EpiLCs induced, in turn, from naïve embryonic stem cells (ESC) 
(Hayashi et al., 2011). PGCLCs and PGCs share molecular identity, epigenetic reprogramming and 
spermatogenic capacity (Hayashi et al., 2011, 2012, 2017). The TF OTX2, a key determinant of 
brain development (Acampora et al., 1995), is also expressed in pluripotent cells in vivo and in vitro 
(Acampora et al., 2013). OTX2 is required to: antagonize naïve pluripotency; promote transition of 
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ESCs from naïve to formative pluripotency; specify the heterogeneous identity of ESCs through 
reciprocal antagonism with NANOG; and define in vitro and in vivo naïve-primed intermediate 
states of pluripotency (Acampora et al., 2013, 2016, 2017 Buecker et al., 2014; Yang et al., 2014; 
Neagu et al., 2020). Moreover, in pluripotent cells OTX2 may also bind to the enhancer region of 
Oct4, Nanog and Sox2 (Acampora et al., 2016). Recent work has revealed that OTX2 is a novel 
crucial determinant controlling germline entry of formative epiblast cells in mouse (Zhang et al., 
2018; Zhang and Chambers, 2019; Laird, 2018). Indeed, by restricting germline entry to a limited 
number of epiblast-derived cells, OTX2 controls segregation of germ cells from somatic precursors. 
Here, we hypothesized that mechanistically, entry into germline requires the release by OTX2 of a 
repressive state preventing activation of the pluripotency GRN in epiblast-derived cells. Our data 
indicate that loss of OTX2 binding to Oct4 or Nanog enhancer region causes in EpiLC-derived cells 
widespread activation of the pluripotency GRN, increased germline entry and suppression of 
somatic fate. Generation of PGCs is increased also in mutant embryos. This study uncovers a novel 

















OTX2, OCT4 and NANOG expression during PGC development and PGCLC differentiation 
To obtain a detailed view of the temporal appearance of OTX2, OCT4 and NANOG relative to 
germline and somatic differentiation determinants, embryos were analysed by immunofluorescence 
(Fig.1A). At embryonic day (E) 6.5, AP2γ and BLIMP1 were co-expressed in a subset of 
FRAGILIS+ (also known as Ifitm3) cells, which included incipient PGCs (Zhang et al., 2018). From 
E7 to E7.5 these three markers gradually became co-localized in PGCs (yellow arrows in Fig. 1A). 
At E6.5 and E7, OTX2 was expressed in some FRAGILIS+-AP2γ- cells (white arrow in Fig. 1A), 
but became undetectable at E7.5 in FRAGILIS+ cells. During this time window, OCT4 and 
NANOG were co-expressed in FRAGILIS+ cells, though at E6.5 NANOG was detected at variable 
levels (Fig. 1A). T was initially expressed throughout the FRAGILIS+ field but by E7.5 disappeared 
from some FRAGILIS+ cells (Fig. 1A). These data show that AP2γ and BLIMP1 become expressed 
within FRAGILIS+ cells only when OTX2 has been turned off suggesting that expression of OTX2 
in FRAGILIS+ cells may prevent precocious activation of AP2γ and BLIMP1.  
To determine whether these temporal changes in expression were mirrored in vitro, we analysed 
EpiLC-derived cell aggregates during PGCLC differentiation by using a modification of the 
established procedure (Hayashi et al., 2011) in which the concentrations of BMP4, BMP8a, SCF 
and EGF were reduced ten-fold (protocol 1) as used previously (Zhang et al., 2018) (Fig. 1B). 
AP2γ+ cells were first detected at day (d) 0.5; at d1 some AP2γ+ cells co-expressed BLIMP1 and 
these increased in number up to d2; OCT4 was expressed in all cells up to d1 with expression 
remaining high in AP2γ+ cells at d2; NANOG was activated at high levels predominantly in AP2γ+-
T- cells; and T showed widespread activation beginning at d1 prevalently in AP2γ- cells expressing 
low level of NANOG (Fig. 1C). A comparison of OTX2 expression with that of OCT4, NANOG, 
AP2γ and T showed that, although markedly down-regulated between d0 and d1 (Zhang et al., 
2018) and virtually undetectable at d2 (Fig. 1C), OTX2 remained detectable at d0.5 and d1 in 
numerous cells co-expressing OCT4 and low levels of NANOG and from d1 also T (Fig. 1C). 
Notably, at d0.5 OTX2 was absent from AP2γ+ cells. This analysis confirms and extends previous 
finding (Zhang et al., 2018) indicating that during the germline and somatic differentiation time 
window, OTX2 is efficiently repressed in epiblast-derived or EpiLC-derived cells as they begin to 
differentiate towards PGCs or PGCLCs, while it is maintained for longer in somatic precursors. 
This suggests that differential OTX2 repression may prevent excessive germline differentiation. 
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OTX2 binding to Nanog or Oct4 enhancer region regulates the generation of PGCLCs and 
somatic cells 
To assess the hypothesis that differential OTX2 repression governs the extent of germline entry, we 
analysed ESCs in which specific OTX2 binding site(s) (Obs) were mutagenized. Nanog∆Obs3 
ESCs have lost the strongest Obs (Obs3) in the Nanog enhancer (Acampora et al., 2016). In 
addition, we derived Oct4∆Obs ESC lines mutagenized in the three Obs located in the enhancer 
region of Oct4 (Fig. S1A-D): Obs1 within the PE, Obs2 at the 5' of the PE, and Obs3 at the 3' of the 
DE (Fig. S2A). Compared to wild type (wt), the OTX2 binding activity in Oct4∆Obs ESCs and d2 
EpiLCs was virtually abrogated (Fig. S2B). However, wt and Oct4∆Obs ESCs showed no 
differences in self-renewal at clonal density (Fig. S2C; Table S1), expression of OCT4, NANOG, 
OTX2 and OCT6 (also known as Pou3f1) (Fig. S2D), ability to convert into the naïve state (Fig. 
S2E), steady state of LIF, FGF, WNT and BMP signaling (Fig. S2F), acute responsiveness to LIF 
(Fig. S2G) and FGF2 (Fig. S2H) and chimaera-forming capacity (Fig. S2I). Furthermore, analysis 
of Oct4∆Obs and Nanog∆Obs3 EpiLCs at d2 showed uniform high level of OCT4, OTX2 and 
OCT6, absence of NANOG and T (Fig. S2J) and similar steady state levels of phospho (p)-ERK1,2, 
p-SMAD1,5,8, p-ßCATENIN, active ß-CATENIN and p-SMAD2 (Fig. S2K). Together these 
results indicate that Oct4∆Obs ESCs and both Oct4∆Obs and Nanog∆Obs3 EpiLCs are 
indistinguishable from wt cells. 
To investigate whether Oct4∆Obs and Nanog∆Obs3 (subsequently referred to as ∆Obs) ESCs are 
affected in their propensity to differentiate into germline cells, we employed the above mentioned 
protocol 1 as PGCLC differentiation method (Fig. 2A). FACS analysis (Fig. S3A-C) for SSEA1 
(also known as Fut4) and CD61 (also known as Itgb3), which are co-expressed in PGCLCs, 
indicated that compared to wt, ∆Obs mutants generated at d6 a higher percentage of SSEA1+-
CD61+ cells, approaching that of Otx2 null (Otx2KO) cells (Zhang et al., 2018) (Fig. 2B). This 
finding was confirmed with independently generated ∆Obs cell lines (Fig. 2C). To determine 
whether increased generation of PGCLCs was presaged by altered expression of TFs, cytospin 
preparations of d2 cell aggregates were analyzed. Relative to wt, ∆Obs mutants showed an 
increased proportion of cells expressing high levels of OCT4, NANOG and BLIMP1 and a 
decreased proportion of T+ cells (Fig. 2D; Fig. S3D,E; Table S2). Immunohistochemistry analysis 
of d2 cell aggregates supported cytospin data (Fig. 2E). Real-time quantitative PCR (RT-qPCR) 
analysis indicated that also the expression levels of Oct4, Nanog, Ap2γ and Blimp1 were increased 
at d2 in mutants (Fig. 2F). For Nanog and Blimp1 this was apparent at d0,5, for Ap2γ it was evident 
at d0.25 (Fig. 2F). No difference in Otx2 expression was detected between wt and ∆Obs mutants, 
while the expression levels of T and Hoxb1 were substantially diminished in ∆Obs mutants and 
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virtually extinguished in Otx2KO cells (Fig. 2F,G). Previous studies reported that histone H3 tri-
methyl lysine 9 (H3K9me3) is enriched at poised enhancers and may distinguish poised and active 
states for the DE and PE of Oct4 (Wu and Schöler, 2014). Compared to wt, in Oct4∆Obs d2 cell 
aggregates, the H3K9me3 level was reduced on the DE (Fig. 2H) suggesting a repressive role for 
OTX2 on DE activity. Increased generation of SSEA1+-CD61+ cells was observed in mutants also 
when PGCLC differentiation was initiated from ESCs maintained in serum plus LIF (protocol 2) 
(Fig. 2I,J; Fig. S4A). Therefore, in contrast to wt and similar to Otx2KO cells, germline 
differentiation of ∆Obs mutants is increased at the expense of somatic fate. 
 
Cytokine requirements for germline and somatic differentiation of ∆Obs mutants 
Otx2KO EpiLCs can undergo germline entry in the absence of cytokines (Zhang et al., 2018). To 
determine whether ∆Obs EpiLCs possessed the same capacity, we employed a cytokine-free 
differentiation protocol (protocol 3) (Fig. 3A). FACS analysis at d6 revealed moderate generation of 
PGCLCs only in Otx2KO cells (Fig. 3B). Cell counting and immunohistochemistry experiments 
showed that at d2 ∆Obs mutants significantly increased the percentage of total cells expressing high 
OCT4 and high NANOG and decreased the proportion of T+ cells (Fig. 3C; Figs. S3D,E and S4B; 
Table S2). The BLIMP1+ cell fraction was expanded only in Otx2KO cells. RT-qPCR analysis 
showed that repression of Otx2 was equally delayed in all genotypes and that expression of Nanog, 
Oct4, Ap2γ , Blimp1, and T at d2 was coherent with cell counting data (Fig. 3D). At earlier time 
points, the expression of these factors was similar in all genotypes except for Blimp1 and Ap2γ, 
which were increased and precocious in Otx2KO cells (Zhang et al., 2018) (Fig. 3D). Hoxb1 was 
inefficiently up-regulated in mutants (Fig. 3E). Therefore, in the absence of cytokines, ∆Obs 
mutants, in contrast to Otx2KO cells, are unable to promote germline differentiation. This suggests 
that cytokine-independent germline differentiation of ∆Obs mutants may require OTX2 functions in 
addition to those depending on OTX2 binding to Oct4 or Nanog enhancer region. LIF is required 
for proliferation and survival of germ cells (Hayashi et al., 2011; Farini et al., 2005; Koshimizu et 
al., 1996; Cheng et al., 1994) and to maintain pluripotency and promote self-renewal of ESCs 
(Matsuda et al., 1999; Niwa et al., 2009). Since these functional properties may have an impact on 
germline differentiation of ∆Obs and Otx2KO mutants, we analyzed cell aggregates cultured with 
LIF only (protocol 4) (Fig. 4A). Compared to wt, ∆Obs and Otx2KO mutants generated more 
PGCLCs at d6 (Fig. 4B), and at d2 showed increased percentage of total cells expressing high 
OCT4, high NANOG and BLIMP1 and a virtual absence of T+ cells (Fig. 4C; Figs. S3D,E and 
S4C; Table S2). RT-qPCR analysis showed that Otx2 was efficiently repressed in all genotypes (Fig. 
4D), while, compared to wt, in mutant cell aggregates Oct4 expression was maintained high, 
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Blimp1, Ap2γ , and Nanog were activated earlier, T and Hoxb1 severely decreased (Fig. 4D,E). 
Therefore, LIF is sufficient to promote significant germline differentiation in ∆Obs mutants and, 
with a substantially higher efficiency, in Otx2KO cells. 
To further investigate the contribution of LIF to PGCLC differentiation, we used a protocol in 
which LIF was the only component omitted from the cytokine cocktail (protocol 5) (Fig. 4F). 
Compared to wt, the number of PGCLCs at d6 was increased in ∆Obs and Otx2KO mutants (Fig. 
4G). At d2 the percentage of total cells expressing high OCT4, high NANOG and BLIMP1 was 
significantly increased in all mutants, while the number of T+ cells was strongly affected only in 
Otx2KO cells (Fig. 4H; Figs. S3D,E and S4D; Table S2). RT-qPCR analysis showed that repression 
of Otx2 and activation of Nanog, Blimp1 and Ap2γ  were both less efficient than in protocols 1 and 
4 (Fig. 4I). Compared to wt, T and Hoxb1 activation was weakened in mutants (Fig. 4I,J). Taken 
together, findings from protocols 4 and 5 indicate that LIF alone provides a more effective 
stimulation of PGCLC differentiation than the remaining cytokines, and is particularly effective in 
suppressing somatic fate. 
Previous work showed that endogenous WNT activity contributes to Otx2 repression in different 
contexts and can be mimicked by the Glycogen synthase kinase 3 inhibitor (GSK3) CHIR99021 
(CHIR) (Acampora et al., 2016; Neagu et al., 2020; Zhang et al., 2018). We therefore assessed 
whether CHIR alone may stimulate the generation of PGCLCs and somatic mesoderm (protocol 6) 
(Fig. 5A). Only Otx2KO cells produced a substantial proportion of SSEA1+-CD61+ cells at d6 (Fig. 
5B). Compared to wt and Otx2KO mutants, in ∆Obs mutants CHIR treatment generated 
intermediate percentages of cells expressing high OCT4, high NANOG and T (Fig. 5C; Figs. S3D,E 
and 5A; Table S3) and intermediate expression levels of Oct4, Nanog, T and Hoxb1 (Fig. 5D,E). 
However in wt and ∆Obs mutants the percentage of BLIMP1+ cells and the expression levels of 
Blimp1 and Ap2γ were both similar to those described in cytokine-free culture conditions (Fig. 
5C,D). RT-qPCR analysis showed that Otx2 repression was comparable to that observed in protocol 
5 (Fig. 5D). These results reveal that stimulation of the WNT pathway induces robust PGCLC 
differentiation only in Otx2KO cells, while in ∆Obs and Otx2KO mutants it efficiently suppresses 
somatic differentiation. 
 
LIF, WNT and BMP4 synergism promotes germline entry in ∆Obs mutants  
To determine whether WNT stimulation may synergize with LIF signaling during PGCLC 
differentiation, as reported for ESCs (ten Berge et al., 2011; Karwacki-Neisius et al., 2013;  Ogawa 
et al., 2006), we assessed the effects of simultaneous addition of LIF and CHIR (protocol 7) (Fig. 
5F). Compared to wt, the generation of PGCLCs at d6 was substantially higher in ∆Obs and 
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Otx2KO mutants (Fig. 5G). This correlated with increased percentage of total cells expressing high 
OCT4, high NANOG and BLIMP1, severe decrease of T+ cells (Fig. 5H; Figs. S3D,E and S5B; 
Table S3) and precocious and robust expression of Nanog, Blimp1 and Ap2γ (Fig. 5I). In addition T 
and Hoxb1 were not activated and Otx2 was efficiently repressed (Fig. 5I,J). To explore whether 
low levels of stimulation of other pathways could likewise potentiate the effects of LIF, we assessed 
differentiation in the presence of LIF and a low dosage of BMP4, BMP8a, SCF and EGF (protocol 
8) (Fig. 6A), whose concentrations were ten times lower than those used in protocols 1 and 5. 
Compared to wt, ∆Obs and Otx2KO mutants showed that PGCLC generation at d6 (Fig. 6B) and 
number of cells expressing at d2 high OCT4, high NANOG and BLIMP1 were both markedly 
increased, while the number of T+ cells was considerably diminished (Fig. 6C, Figs. S3D,E and 
S5C, Table S3). RT-qPCR assays showed expression profiles similar to those obtained with LIF 
plus CHIR (Fig. 5I,J). Compared to protocol 8, cell aggregates supplemented only with low 
concentrations of BMP4, BMP8a, SCF and EGF showed that the generation of SSEA1+-CD61+ 
cells was reduced in Otx2KO cells and virtually absent in ∆Obs mutants (Fig. S6A,B). Therefore, 
data from protocols 7 and 8 indicate that in ∆Obs mutants, LIF addition to CHIR or to a minimal 
dosage of BMP4, BMP8a, SCF and EGF promotes efficient germline entry and severely affects 
somatic lineage. Based on these results, we asked whether combining LIF with CHIR and low 
dosage of BMP4, BMP8a, SCF and EGF (protocol 9) could further augment PGCLC differentiation 
(Fig. 6F). Interestingly, the number of PGCLCs (Fig. 6G), the percentage of total cells expressing 
high OCT4, high NANOG, BLIMP1 and T (Fig. 6H, Figs. S3D,E and S5D, Table S3) and the 
expression profile exhibited by Otx2, Oct4, Nanog, Ap2γ, Blimp1, T and Hoxb1 (Fig. 6I,J) were all 
similar to those obtained using the protocol 1. Furthermore, the level of H3K9me3 detected in 
Oct4∆Obs cells was decreased on the DE and increased on the PE (Fig. 6K), suggesting that, as 
shown for protocol 1, OTX2 is required to prevent transition of the DE status from a poised to an 
active condition. To further assess the similarities between mature PGCLCs generated by protocols 
1 and 9, expression of PGCLC-specific mRNAs was examined by RT-qPCR. SSEA1+-CD61+ cells 
purified at d6 using protocols 1 and 9 showed very similar expression of 11 PGCLC-specific 
mRNAs in both wt and mutant PGCLCs (Fig. S6C).Therefore, in ∆Obs mutants LIF, CHIR and low 
dosage of BMP4, BMP8a, SCF and EGF may cooperatively induce high levels of PGCLCs 
counterbalanced by severe decrease of somatic cells. Through this cooperation ∆Obs mutants 
exhibit close similarity with Otx2KO cells, a finding previously reported only for protocol 1. The 
significance of these data was reinforced by a further control experiment showing that in presence 
of CHIR and low dosage of BMP4, BMP8a, SCF and EGF, the generation of PGCLCs was 
considerably increased only in Otx2KO cells (Fig. S6D,E). To further investigate the role of LIF, 
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the effect of titrating the LIF concentration on PGCLC differentiation was assessed. In GK15 media, 
the percentage of SSEA1+-CD61+ cells detected in wt cells was low but increased with increasing 
LIF concentrations, up to about 6% (Fig. S7A). In contrast, the mutant cell aggregates showed an 
increased yield of SSEA1+-CD61+ cells at 1000 U/ml LIF, compared to 300 U/ml, but this was not 
further increased by raising the LIF concentration to 3000 U/ml (protocol 4) (Fig. S7B). When a 
similar LIF titration was performed using the fixed concentrations of CHIR and low dosage of 
BMP4, BMP8a, SCF and EGF (protocol 9; Fig. S7C) a similar pattern of response was observed in 
both wt cells and in all mutant cell lines (Fig. S7D). While the absolute proportions of SSEA1+-
CD61+ cells was increased in each cell line, the saturating response was seen in all the mutants to 
1000 U/ml LIF but not in the wt cells (Fig. S7B), which at 3000 U/ml of LIF increased the 
percentage of PGCLCs up to 11%.  
 
Temporal expression changes during early PGCLC differentiation of ∆Obs mutants 
Previous data showed that the OTX2 repressive control of Oct4 and Nanog expression defines 
commitment of EpiLC-derived cells to germline or somatic lineage. To deepen this aspect, we 
analyzed the combined expression of OTX2, OCT4, NANOG, SOX2, AP2γ and T in wt and ∆Obs 
cell aggregates at d0.5 and d1 using protocol 1. OCT4 and SOX2 were uniformly co-expressed in 
wt and ∆Obs cells, while NANOG was detected mostly at low level in wt and at high level in ∆Obs 
cells (Fig. S8). Although, compared to EpiLCs, the Otx2 mRNA was down-regulated at d0.5 and d1 
(Fig. 2F), OTX2 was detectable in numerous cells co-expressing OCT4 and low NANOG in wt 
aggregates but co-expressing OCT4 and prevalently high NANOG in ∆Obs mutants (Fig. S8). All 
NANOG+ cells co-expressed SOX2 (Fig. S8). In wt cells at d0.5 AP2γ was detected in very few 
OTX2- cells co-expressing high NANOG, while in ∆Obs mutants AP2γ was activated in a higher 
number of cells all co-expressing high NANOG and, frequently also OTX2 (Fig. S8), suggesting 
that in ∆Obs mutants numerous OTX2+ cells are permissive for AP2γ activation. However, by d1 
AP2γ co-expression with OTX2 was lost, likely for further down-regulation of OTX2 in AP2γ+ 
cells. Analysis of T showed that at d1 in wt cells most of the OTX2+ cells co-expressed T and low 
NANOG, while in ∆Obs mutants the few T+ cells co-expressed only low NANOG (Fig. S8). These 
data suggest that OTX2-dependent, widespread activation of the pluripotency GRN determines in 
mutants a precocious and extensive recruitment of EpiLC-derived cells for germline entry rather 





The Obs2 in the Oct4 enhancer plays a major role in germline and somatic differentiation 
To determine which Obs in the Oct4 enhancer is functionally relevant, we restored in the Oct4∆Obs 
mutant the wt sequence of Obs2, which exhibited the highest OTX2 binding activity, and generated 
the Oct4∆Obs1,3 ESC line (Fig. S1E,F). ChIP analysis showed the expected recovery in OTX2 
binding specifically at Obs2 (Fig. S9A,B). FACS analysis showed that the percentage of PGCLCs 
generated by using protocol 1 was similar in wt and Oct4∆Obs1,3 mutant (Fig. S9C). 
Immunohistochemistry and cell counting at d2 (Figs. S9D,E and S3D,E; Table S2) confirmed the 
Oct4∆Obs1,3 similarity to wt cells, suggesting that OTX2 binding to Obs2 modulates the OCT4 
requirement for germline and somatic differentiation.  
 
Enforced OTX2 expression inefficiently suppresses germline entry in ∆Obs mutants 
Previous work showed that Tamoxifen (Tx)-mediated nuclear translocation of OTX2-ERT2 fusion 
protein in wt and Otx2KO cells suppresses PGCLC differentiation (Zhang et al., 2018). We 
reasoned that, in contrast to wt and Otx2KO cells, nuclear translocation of OTX2-ERT2 in ∆Obs 
mutants should not affect functions depending on OTX2 binding to Oct4 or Nanog enhancer region. 
To test this hypothesis, we generated E14;Otx2ERT2, Oct4∆Obs;Otx2ERT2, Nanog∆Obs3;Otx2ERT2 
and Otx2KO;Otx2ERT2 ESC lines expressing similar level of OTX2-ERT2 (Fig. S1G,H). In these 
cell lines Tx exposure for 1 hour induced efficient OTX2-ERT2 nuclear translocation (Fig. S1I). 
Two independent clones for Oct4∆Obs;Otx2ERT2 and Nanog∆Obs3;Otx2-ERT2 mutants were 
compared to E14;Otx2ERT2 and Otx2KO;Otx2ERT2 cell lines using protocol 1. Without Tx, the 
generation of PGCLCs was similar to that of the same parental cell lines (Fig. 7A). In Tx-treated 
cell aggregates (from d0 to d2 of the cell aggregation phase), the generation of PGCLCs was 
suppressed in E14;Otx2ERT2 and Otx2KO;Otx2ERT2 cell lines, severely affected in 
Oct4∆Obs;Otx2ERT2 cells, but only partially impaired in Nanog∆Obs3;Otx2ERT2 cells (Fig. 7B). 
Consistent with these findings, in Tx-treated d2 cell aggregates the generation of AP2γ+-BLIMP1+ 
cells was virtually abolished in E14;Otx2ERT2 and Otx2KO;Otx2ERT2 cells, decreased in 
Oct4∆Obs;Otx2ERT2 cells, but was less affected in Nanog∆Obs3;Otx2ERT2 cell aggregates (Fig. 
7C). Conversely, the generation of T+ cells was severely impaired only in Nanog∆Obs3;Otx2ERT2 
cells (Fig. 7C). Interestingly, in E14;Otx2ERT2, Otx2KO;Otx2ERT2 and Oct4∆Obs;Otx2ERT2 cell 
lines, OCT4 expression was low in all cells including those AP2γ+ (Fig. 7C), which did not activate 
NANOG and SOX2 (yellow and white arrows in Fig. 7C). In contrast, in Nanog∆Obs3;Otx2ERT2 
mutant, a large fraction of AP2γ+ cells showed high expression of OCT4 (pink arrows in Fig. 7C), 
NANOG and SOX2 (Fig. 7C). These data suggest that OTX2 binding to the Nanog enhancer is 
required to efficiently suppress germline differentiation and induce somatic fate. To investigate the 
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possibility that OTX2 may repress germline determinants, we analyzed whether BLIMP1+ cells co-
expressed nuclear OTX2-ERT2. BLIMP1 and OTX2-ERT2 were co-localised in Tx-treated cells of 
all   genotypes (Fig. 7D), which, in turn, also co-expressed AP2γ (Fig. 7C). In addition, we found 
that levels of Prdm14 and Blimp1 mRNAs, which are restricted to PGCLCs, showed a similar 
expression pattern in all cell lines (Fig. 7E). These data suggest that OTX2 does not directly repress 
Blimp1, Ap2γ and Prdm14 during germline differentiation.  
 
∆Obs embryos generate supernumerary PGCs 
To determine whether PGC development was affected also in vivo, we analysed ∆Obs homozygous 
embryos. Immunohistochemistry analysis at E6.7 and E7.5 revealed that expression of BLIMP1, 
AP2γ, FRAGILIS, NANOG, OCT4, T and OTX2 was similar to wt embryos (Fig. 8A). To 
determine the number of BLIMP1+-FRAGILIS+ PGCs we analyzed wt and ∆Obs embryos at E7.5 
and E8.5. All sections including BLIMP1+-FRAGILIS+ PGCs were captured for cell counting (Fig. 
S10). Compared to wt, ∆Obs mutants exhibited about 1.5 times more PGCs at both E7.5 and E8.5 
(Fig. 8B, Table S4). Ectopic PGCs were not identified. Therefore, binding of OTX2 to Oct4 or 




Differentiation of the epiblast into germline and somatic cells both in vivo and in vitro requires the 
action of BMP4, but the interplay with other signals, particularly WNT3, is also notable (Lawson et 
al., 1999; Saitou and Yamaji, 2012; Günesdogan and Surani, 2016; Aramaki et al., 2013). Previous 
studies have reported that LIF is required to sustain proliferation and survival of germ cells 
(Farini et al., 2005; Koshimizu et al., 1996; Cheng et al., 1994).  The initial transition of epiblast-
derived cells into the germline competent state requires dismantling of the formative pluripotency 
GRN, characterised by high Otx2 expression and PE-driven expression of Oct4, alongside 
activation of the PGC pluripotency GRN, characterised by extinction of Otx2, re-expression of 
Nanog, high Sox2 expression and DE-driven expression of Oct4 (Zhang and Chambers, 2019; 
Smith, 2017; Choi et al., 2016). Conversely, somatic differentiation requires transition of formative 
pluripotency into a primed state characterized by cell heterogeneity in expression of pluripotency 
TFs including OTX2, NANOG and SOX2 as well as somatic gene expression.  
Recent work has revealed that, in a germline permissive environment, down-regulation of Otx2 
determines the number of epiblast-derived cells entering the germline differentiation program 
(Zhang et al., 2018; Zhang and Chambers, 2019, Laird, 2018). Nevertheless, the mechanisms by 
which OTX2 regulates the contribution of epiblast cells to germline and somatic lineage are 
unknown. Since OTX2 binds to regulatory regions of Oct4 and Nanog in EpiLCs (Acampora et al., 
2016), we hypothesized that germline entry may require release of OTX2 repression on the PGCLC 
pluripotency GRN. Our data indicate that through this binding, OTX2 influences germline and 
somatic fate choice of EpiLC-derived cells in response to LIF and high dosage of BMP4, BMP8a, 
EGF and SCF. Indeed, ∆Obs and Otx2KO cell aggregates exhibit comparable phenotypes in terms 
of widespread activation of the pluripotency GRN, increased generation of PGCLCs and 
suppression of somatic fate. However, ∆Obs and Otx2KO mutants do not share all aspects of their 
phenotype in all protocols. Importantly, without cytokines, ∆Obs mutants, unlike Otx2KO cells 
(Zhang et al., 2018), do not generate PGCLCs. This suggests that OTX2 blocks cytokine-
independent germline differentiation through functions other than those operating via binding to 
Oct4 or Nanog. Such additional OTX2 functions could involve repression of PGCLC TFs. 
However, our evidence suggests that OTX2 does not directly repress Blimp1, Prdm14 and Ap2γ. 
To determine the signaling pathway modulations that may provide equally efficient PGCLC 
differentiation in ∆Obs and Otx2KO mutants, we analysed the effects of LIF, WNT or BMP4 
alone (protocols 4-6). None of these protocols raises the efficiency of PGCLC generation by 
∆Obs cells to the level achieved in Otx2KO mutants. However, the combined action of LIF, CHIR 
and a low dosage of BMP4, BMP8a, EGF and SCF suppresses the OTX2 functions that hamper 
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∆Obs mutants from highly efficient, Otx2KO-like, germline entry to the same extent as in culture 
conditions with LIF and high dosage of BMP4, BMP8a, EGF and SCF. These data suggest that the 
generation of germ cells may be quantitatively correlated to specific combinations of cytokines 
whose inducing efficiency may be influenced also by the genetic state of the responding cells.  In 
this context it would be interesting to assess whether in embryos the proximal-posterior epiblast 
includes restricted sub-domains where identity and fate of epiblast-derived cells are precisely 
regulated by different concentrations of LIF, BMP and WNT signaling molecules.  
Together with dosage-dependent experiments (Fig. S7), our data indicate that LIF has an 
important role in PGCLC differentiation. We suggest that LIF signaling may improve the 
generation of PGCLCs by enhancing the proliferation/self-renewal of those cells that have 
released OTX2-dependent suppression of the pluripotency GRN. This interpretation may 
explain the beneficial effect of LIF on the generation of PGCLCs in all protocols where it is 
included, and, in addition, supports the similarity with ESCs where LIF is required to maintain 
pluripotency and self-renewal (Matsuda et al., 1999; Niwa et al., 2009), even through synergism 
with WNT and BMP4 signaling (ten Berge et al., 2011; Karwacki-Neisius et al., 2013; Ogawa et 
al., 2006; Ying et al., 2003, 2008). Notably, since Otx2KO ESCs can self-renew in the absence of 
LIF (Acampora et al., 2013), this might explain the propensity of Otx2KO ESCs to enter 
germline in the absence of LIF. We propose that in wt cells, LIF, BMP4 and WNT cooperate to 
repress Otx2 early during the cell aggregation phase (Fig. 9). This generates two types of EpiLC-
derived cells: those lacking OTX2 (OTX2-) (right in Fig. 9A) and those transiently retaining OTX2 
(OTX2+) (left in Fig. 9A). OTX2- cells cannot repress the PGCLC pluripotency GRN, enter the 
unipotent germline state, are expanded by LIF or LIF in synergism with BMP4 and/or WNT and 
differentiate into PGCLCs (right in Fig. 9A). Conversely, OTX2-mediated repression of the 
PGCLC pluripotency GRN in OTX2+ cells promotes entry into primed pluripotency and activation 
of somatic determinants leading to differentiation into somatic mesoderm (left in Fig. 9A). Our data 
do not exclude the possibility that BMP4 and WNT may also facilitate activation of somatic 
mesoderm genes (left in Fig. 9A). In ∆Obs mutants (Fig. 9B), Otx2 repression by LIF, BMP4 and 
WNT and generation of OTX2- (right in Fig. 9B) and OTX2+ (left in Fig. 9B) EpiLC-derived 
subtypes is comparable to wt cells. In ∆Obs mutants the OTX2- EpiLC-derived cell fraction 
corresponds to the wt OTX2- cell fraction, is naturally competent for germline differentiation 
and is unaffected by loss of OTX2 binding to Oct4 or Nanog enhancer region (right in Fig. 
9A,B). However, in the OTX2+ cell fraction, progression towards the somatic fate is impaired by 
the inability of OTX2 to repress the pluripotency GRN (left in Fig. 9B). Consequently, cells that 
activate the pluripotency GRN may be further expanded by cytokines and commit to germline 
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entry. These early events result in an increased recruitment of EpiLC-derived cells for germline 
entry before somatic differentiation is initiated with a consequent switch from somatic to 
germline fate (Fig. 9B). According to this model, nuclear translocation of OTX2-ERT2 can revert 
the germline to somatic fate switch in all cell lines except Nanog∆Obs3;Otx2ERT2 cells (Zhang et 
al., 2018), indicating that OTX2 binding to the Nanog enhancer region efficiently suppresses 
the PGCLC pluripotency GRN. Interestingly, compared to Oct4∆Obs;Otx2ERT2 cells, 
Nanog∆Obs3;Otx2ERT2 mutants produced a higher proportion of presumptive PGCLCs in the 
presence of Tx, indicating that OTX2 suppression of Nanog transcription may play a greater role in 
preventing PGCLC differentiation than suppression of Oct4 transcription. A possible explanation 
may reside in the expression baseline exhibited by Nanog and Oct4 in EpiLCs. Indeed for Nanog, 
transition from the EpiLC state to the cell-aggregation phase is accompanied by re-activation from a 
silent state while for Oct4 this transition does not involve activation of expression, which is similar 
in EpiLCs and early EpiLC-derived cell aggregates, rather a change in its expression control from 
the PE to DE. Moreover, only in Tx-treated Nanog∆Obs3;Otx2ERT2 cells, activation of Nanog is 
accompanied by induction of Sox2 in presumptive PGLCs suggesting that NANOG is required to 
induce Sox2 and that both of them activate DE-driven expression of Oct4 when OTX2 is suppressed. 
Notably, NANOG and SOX2 have been reported to bind to the DE of Oct4 (Wu and Schöler, 2014). 
Importantly, this study shows that the repressive control exerted by OTX2 on Oct4 or Nanog 
also occurs in ∆Obs homozygous embryos, which exhibit increased number of PGCs. Notably, 
PGC generation is not detected at ectopic sites in mutant embryos. This suggests that only 
proximal-posterior epiblast-derived cells, which lie close to the BMP4 source in the 
extraembryonic ectoderm, respond to loss of OTX2 binding to the Oct4 or Nanog enhancer 
region by expanding generation of PGCs. However, our data do not currently distinguish 
between mechanisms involving a somatic mesoderm to germline fate switch of epiblast-derived 
cells or an alternative, cell-autonomous preferential proliferation of PGC precursors. In sum, 
previous work identified Otx2 as a crucial determinant controlling allocation of epiblast cells to 
germline or somatic lineage (Zhang et al., 2018). Here we show that repression of Oct4 and 
Nanog is a major mechanism by which OTX2 balances the contribution of epiblast cells to 
germline and somatic lineage, and, in addition, that OTX2 plays further roles preventing 






MATERIALS AND METHODS 
Generation of ESC and mouse mutants 
Mutant ESC lines were generated by homologous recombination into E14Tg2a cells. The 
Nanog∆Obs3 ESC lines corresponding to clones 1 and 7, have previously been described 
(Acampora et al., 2016). In this study clone 1 was used for all experiments and clone 7 for 
independent confirmatory assays (Fig. 2).  As for the Oct4∆Obs ESC line, the mutant version of 
Obs1, Obs2 and Obs3 (Fig. S1A), was first introduced in the 5’ flanking sequence of the Oct4 gene 
by PCR-mediated mutagenesis, and then, this region was inserted into the targeting vector. Correct 
targeting into ESCs was assessed by Southern blot with probe a (Fig. S1B,C). Two Oct4∆Obs-
neo/+ ESC clones were subjected to alternate rounds of neomycin cassette removal and re-targeting 
to obtain two independent homozygous ESC lines corresponding to clones 3 and 24 as confirmed 
by Southern blot and PCR analysis (Fig. S1C,D). Clone 24 represented an independent clone for 
confirmatory experiments (Fig. 2). The Oct4∆Obs clone 3 was employed to perform all the 
experiments reported in this study. The Oct4∆Obs/+ ESC clone used to generate the Oct4∆Obs 
clone 3, was also injected into C57BL/6 blastocysts to establish a mouse colony, which was kept 
into the B6D2 genetic background. Oct4∆Obs homozygous mice were healthy and fertile. The 
homozygous Oct4∆Obs1,3 ESC line was also obtained by two alternate rounds of targeting and 
neomycin cassette removal in the homozygous Oct4∆Obs cell line, by using a targeting vector 
carrying the mutant version of Obs1 and Obs3 sequences, but with the Obs2 sequence reverted to 
that of the wild type gene (Fig. S1E). Genotyping of the homozygous Oct4∆Obs1,3 cells was 
confirmed by PCR with allele-specific primers (Fig. S1F) and Southern blot (not shown). Primers 
for genotyping are listed in Table S5. The pPyCAGOtx2-ERT2 plasmid (Zhang et al., 2018) (Fig. 
S1G) was electroporated into E14, Nanog∆Obs3, Oct4∆Obs, and Otx2KO ESCs to generate cell 
lines showing cytoplasmic and ubiquitous distribution of the OTX2-ERT2 fusion protein whose 
nuclear translocation was dependent on 4-hydroxytamoxifen (Tx) (Sigma) administration. 
Twelve randomly integrated clones for each mutant cell line were assayed by Western blot to 
determine transgene expression. ESC lines exhibiting comparable levels of OTX2-ERT2 were 
identified and those showing a level approximately twice that exhibited by the endogenous OTX2 
were selected (Fig. S1H). These clones were then assayed by immunostaining with an antibody 
directed against ER. In the absence of Tx, the OTX2-ERT2 protein was prevalently localized to the 
cytoplasm, whereas 1 hour of Tx (200 nM) exposure was sufficient to confine OTX2-ERT2 to the 
nucleus (Fig. S1I). 
All ESC lines of this study tested negative for mycoplasma contamination. 
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Experiments involving the use of animals were accomplished in accordance with the authorization 
n° 1196/2015-PR released by the Italian Ministry of Health.  
 
Cell culture experiments 
ESCs were either cultured in Glasgow Minimum Essential Medium (GMEM) medium (Sigma) 
supplemented with 12% FBS (HyClone) and 1,000U/ml of Leukemia Inhibitory Factor (LIF) 
(Millipore) (referred to as FBS+LIF), or in serum-free N2B27 medium (Gibco) supplemented with 
500U/ml LIF, 1µM of the Mitogen-activated protein kinase kinase 1/2 (MEK1/2) inhibitor 
PD325901 (PD) and 3µM of the Glycogen synthase kinase 3 (GSK3) inhibitor CHIR99021 (CHIR) 
small molecules (both from Calbiochem) (referred to as LIF+2i) (Ying et al., 2008). Cell aggregates 
were generated from EpiLC  induced from ESCs adapted to LIF+2i medium for a minimum of 
seven passages or maintained in  FBS+LIF. ESCs (2 x 105) were cultured in a 6-well plate coated 
with human fibronectin (Sigma) (16.7 µg/ml) in serum-free N2B27 medium containing 1% 
KnockOut Serum Replacement (KSR, Gibco ThermoFisher), 12 ng/ml of basic Fibroblast Growth 
Factor (FGF2) (PeproTech), and 20 ng/ml Activin A (R&D Systems) for 48 hours (Buecker et al., 
2014).  Then, EpiLCs were dissociated with TrypLE reagents (Gibco ThermoFisher) and 
resuspended at a concentration of 8 x 104 cells/ml in GMEM medium containing 15% KSR (GK15) 
or together with various combinations of cytokines and small molecules. Next, 25µl of cell 
suspension (about 2000 cells) was plated on the lids of tissue culture dishes and incubated, as 
hanging drops, over PBS-containing bottom plates. After two days, cell aggregates were either 
collected for immunohistochemistry on sections and cytospin experiments, or transferred to 
ultralow adhesion 24-well plates (Corning) where they were incubated in the same culture media 
for additional four days before FACS analysis. Medium was replaced every other day. Culture 
conditions for cell aggregates were based on the method reported by Hayashi et al. (Hayashi et al., 
2011).  
In protocol 1 cell aggregates were cultured in GK15 supplemented with LIF (1,000 U/ml), Bone 
Morphogenetic Protein 4 (BMP4) (50 ng/ml), BMP8a (50 ng/ml), Stem Cell Factor (SCF) (10 
ng/ml) (all from R&D Systems), Epidermal Growth Factor (EGF) (10 ng/ml) (PeproTech) (Zhang 
et al., 2018; Hayashi et al., 2011) (Figs. 1B and 2A). Protocol 2 differed from protocol 1 only for 
ESCs that were maintained in FBS+LIF (Fig. 2I). In protocol 3 cell aggregates were cultured only 
in GK15 medium (Fig. 3A). In protocol 4 cell aggregates were cultured in GK15 with LIF 
(1000U/ml) only (Fig. 4A). In protocol 5 cell aggregates were cultured in GK15 supplemented with 
BMP4 (50 ng/ml), BMP8a (50 ng/ml), SCF (10 ng/ml), EGF (10 ng/ml) and without LIF (Fig. 4F). 
In protocol 6 cell aggregates were cultured in GK15 supplemented with CHIR (3µM) only (Fig. 
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5A). In protocol 7 cell aggregates were cultured in GK15 supplemented with LIF (1,000 U/ml) and 
CHIR (3µM) (Fig. 5F). In protocol 8 cell aggregates were cultured in GK15 supplemented with LIF 
(1,000U/ml) and low dosage of BMP4 (5ng/ml), BMP8a (5ng/ml), SCF (1ng/ml) and EGF (1ng/ml) 
(Fig. 6A). In protocol 9 cell aggregates were cultured in GK15 supplemented with LIF (1,000U/ml), 
CHIR (3µM) and low dosage of BMP4 (5ng/ml), BMP8a (5ng/ml), SCF (1ng/ml) and EGF 
(1ng/ml) (Fig. 6F).  
Two additional culture conditions without LIF were employed as control experiments: in the first 
condition, cell aggregates were cultured in GK15 supplemented with low dosage of BMP4 (5ng/ml), 
BMP8a (5ng/ml), SCF (1ng/ml) and EGF (1ng/ml) (Fig. S6A); in the second condition cell 
aggregates were cultured in GK15 supplemented with CHIR (3µM) and low dosage of BMP4 
(5ng/ml), BMP8a (5ng/ml), SCF (1ng/ml) and EGF (1ng/ml) (Fig. S6D).  
For experiments performed to assess the effect of different concentrations of LIF, wt and mutant 
cell aggregates were cultured according to the standard and modified versions of protocols 4 and 9. 
For protocol 4, cell aggregates were cultured for 6 days in GK15 medium supplemented with 300, 
1000 (standard protocol 4) and 3000 U/ml of LIF only (Fig. S7A,B); for protocol 9 cell aggregates 
were cultured in the presence of fixed concentrations of CHIR (3µM) and low dosage of BMP4 
(5ng/ml), BMP8a (5ng/ml), SCF (1ng/ml) and EGF (1ng/ml) in combination with 300, 1000 
(standard protocol 9) and 3000 U/ml of LIF (Fig. S7C,D). 
For experiments involving E14;Otx2ERT2, Oct4∆Obs;Otx2ERT2, Nanog∆Obs3;Otx2ERT2 and 
Otx2KO;Otx2ERT2 cell lines, Tx (200nM) was administered from d0 to d2 of the cell aggregation 
phase both for FACS experiments on d6 and immunohistochemistry and RT-qPCR analyses on d2. 
For these cell lines EpiLC-derived cell aggregates were cultured following protocol 1 conditions. 
 
Alkaline phosphatase (ALP) assay, FGF2 and LIF response experiments 
For ALP staining, 8x102 ESCs cultured in FBS+LIF medium were seeded as triplicates in 6-well 
plates and grown for 5 days. Upon fixation into 10% Neutral Buffered Formalin (Sigma), ALP 
activity was revealed by 30 minutes incubation into a freshly made solution containing 0.1 M Tris-
HCl (pH 8.3), Naphthol AS MX-PO4 (5 mg, pre-dissolved in 200μl of N,N-Dimethylformamide,) as 
phosphatase substrate, and Fast Red Violet (30 mg) as dye (both from Sigma) in a  50 ml final 
volume. After a few washes in water, colonies were scored for those exhibiting homogeneous 
staining and counted. For LIF response experiments, ESCs were kept for up to 1 hour in GMEM 
containing 15% KSR in the absence of LIF, which was then added back to the medium at a 
concentration of 103 Units /ml. p-STAT3 was monitored after 20 minutes by Western blots 
(Acampora et al., 2017). For FGF2 response, ESCs were washed and kept in GMEM containing 5% 
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KSR with or without FGF2 at a concentration of 5 ng/ml for 15 and 45 minutes (Acampora et al., 
2016).  FGF2 response was determined by assessing the level of p-ERK1,2 in Western blots. 
 
ChIP experiments 
ChIP experiments were performed as previously described (Lee et al., 2006) on wt and Otx2KO 
ESCs and EpiLCs with a rabbit polyclonal OTX2 antibody (Acampora et al., 2016), and on d2 cell 
aggregates with a rabbit histone H3 tri-methyl lysine 9 (H3K9me3) antibody and normal rabbit IgG. 
On the day before chromatin preparation, Dynabeads Protein A (Invitrogen) were washed three 
times with PBS containing 0.5% BSA and pre-adsorbed over-night with the different antibodies and 
normal rabbit IgG. Only for aggregates, cells were washed with PBS and trypsinized before fixation. 
Then, formaldehyde (1%) cross-linked cells were quenched with 125 mM glycine and washed twice 
with cold PBS. Upon collection and centrifugation at 4°C, cells were lysed in LB1 buffer (50 mM 
Hepes-KOH, 140 mM NaCl, 1 mM EDTA, 10% glycerol, 0.5% NP-40, 0.25% Triton X-100), then 
were resuspended in LB2 buffer (10 mM Tris-HCl pH 8.0, 200 mM NaCl, 1 mM EDTA, 0.5 mM 
EGTA), rocking at 4°C for 10 min each time. Isolated nuclei were resuspended into LB3 buffer (10 
mM Tris-HCl pH 8, 100mM NaCl, 1mM EDTA, 0.5 mM EGTA, 0.1% Na-Deoxycholate, 0.5% N-
lauroylsarcosine Na-salt) and kept on ice. All lysis buffers were prepared with freshly added 
protease inhibitor cocktail plus PMSF. Sonication was performed with a Misonix 2000 sonicator to 
obtain fragment size with a peak of approximately 500 base pairs or 300 base pairs respectively for 
OTX2 or H3K9me3 ChIP assays. SDS 0.1%, (only for OTX2 ChIP assays) and Triton X-100 (1%) 
were added to sonicated chromatin before centrifugation to remove debris. Supernatant was then 
incubated with the antibody- or IgG-coated beads on a rotator at 4°C for at least 18 hours 
(Acampora et al., 2016). Beads were collected at any step through the magnetic stand and 
sequentially washed with low-salt solution (0.1% SDS, 1% Triton, 2 mM EDTA pH8, 20 mM Tris-
HCl pH 8, 150 mM NaCl), high-salt solution (0.1% SDS, 1% Triton, 2mM EDTA, 20mM Tris-HCl 
pH 8, 500 mM NaCl), LiCl solution (0.25 M LiCl, 1% NP40, 1% Na-Deoxycholate, 10 mM Tris-
HCl pH 8), and TE buffer (Tris-HCl 10mM pH 8, 1 mM EDTA) containing 50 mM NaCl. Beads 
were then incubated for 15 min at 65°C with elution buffer (50 mM Tris-HCl pH 8, 10 mM EDTA, 
1% SDS). The immunoprecipitated DNA (IP) was separated from the beads and reverse crosslinked 
along with input (non-IP DNA) by overnight incubation at 65°C. After RNA and protein digestion, 
DNA samples were purified by Phenol-Chloroform extraction and Ethanol precipitation. DNA was 
resuspended in 10 mM Tris-HCl pH 8 and used in standard qPCR reactions. Fold enrichment of 
OTX2 ChIP samples was calculated relative to ChIP in Otx2KO cells, used as negative control, 
according to the 2-ΔΔCt formula. ChIP values for H3K9me3 and control IgG were calculated as 
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percent of input, according to the formula: % Input =2-ΔCt(normalized ChIP). Data are represented as 
mean ± standard deviation (SD) of three independent experiments, each in technical triplicates. 
ChIP primers are listed in Table S5. 
 
Immunocytochemistry and immunohistochemistry 
For immunocytochemistry experiments on ESCs and EpiLCs, adherent cells grown on 4-well 
chamber slides (Sarstedt) were PBS washed and fixed with 4% paraformaldehyde (PFA). Blocking 
(1 hour) and incubation with primary antibodies (overnight) were performed in PBS containing 
0,3% triton X-100 and 2% skimmed milk powder (BioRad). Cells were washed three times with 
PBS before and after incubation with Alexa fluor secondary antibodies (90 min). Cells were then 
counterstained with Dapi (Acampora et al., 2016). Immunohistochemistry experiments on d2 
PGCLCs were performed on an average of 100-150 cell aggregates per experiment. After washing 
in PBS, cell aggregates were fixed overnight in 4% PFA, then dehydrated and processed for 
paraffin embedding and microtome sectioning. Slides were then xylene-deparaffinized and 
rehydrated through a descending series of alcohol to water before been boiled into citrate buffer pH 
6.0 for antigen retrieval. Sections were then incubated with a blocking solution containing 0.5% 
milk, 10% FBS, 1% BSA and hybridized with the primary and Alexa fluor secondary antibodies as 
described before.  (Acampora et al., 2013). For immunostaining of cytospin preparations, d2 cell 
aggregates were collected, washed twice with PBS, dissociated with trypsin and resuspended in 5% 
FBS in PBS to obtain a single cell suspension. After centrifugation, cells were resuspended at 1x106 
cells/ml in 1% BSA in PBS and 2x105 cells were loaded onto cytofunnels and centrifuged for 7 min 
at 1000 r.p.m. Cells were fixed in 4% PFA and processed for immunostaining as described for 
ESCs and EpiLCs. 
For in vivo PGC counting, embryos obtained from natural matings of age-matched (3 month-old), 
randomly selected breeding pairs of wild type and ∆Obs mutants were collected at E7.5 and E8.5, 
fixed overnight in 4% PFA in PBS, dehydrated, paraffin embedded and sectioned. Embryos 
matched for morphology or number of somites, were processed for immunostaining with 
FRAGILIS and BLIMP1 antibodies as for cell aggregates. All sections including PGCs were 
selected and captured for cell counting. All immunostaining images were captured with a Nikon 
eclipse NI microscope. For immunohistochemistry experiments performed with 3 compatible 
antibodies, fluorescence was excited at 405 nm for Dapi and at 488 nm, 555 nm and 647 nm for 
secondary antibodies. Eventually, red color for fluorescence excited at 555 nm was converted to 
green pseudocolor to allow merging of all combinations. All antibodies employed for 




Cell counting and statistical analysis 
Cytospin assays were immunostained and 3 non-overlapping fields per experiment were captured, 
images were printed in A4 format and cell number manually determined. Standard deviation (SD) 
was calculated from the analysis of three independent experiments for each differentiation protocol 
and for each cell line (Tables S2 and S3). Similarly, also for PGC counting in embryos, 
immunostained sections were selected, captured, printed in A4 format and FRAGILIS+- BLIMP1+ 
cells counted. Embryos were selected by morphology at E7.5 and by morphology and number of 
somites at E8.5. SD was determined by the analysis of 6 and 7 embryos/genotype respectively at 
E7.5 and E8.5 (Table S4). P value was determined by using the one-tail or two tails Student t test.  
 
Flow cytometry  
FACS analysis was performed on d6 cell aggregates. An average of 50-60 aggregates were 
collected and dissociated into single cells with trypsin and neutralized in PBS containing 10% FBS. 
A maximum of 5 x 105 cells were collected by centrifugation and the pellet resuspended in 100μl 
PBS plus 10% FBS supplemented with Alexa Fluor 647 anti-mouse/human CD15 (SSEA1) 
(Biolegend) and PE anti mouse/rat CD61 (Biolegend) (Zhang et al., 2018), diluted 1/200 and 1/500, 
respectively, and incubated for 30 min at 4 °C. Cells were washed twice in 1 ml PBS plus 10% FBS 
before analysis on a BD FACSAria III (Becton Dickinson). Data were acquired using BD 
FACSDiva software 8.0.1 and analyzed using FlowJo software version 10.7.1. Gating strategy is 
shown in Fig. S3A. The dissociated cell population was first gated on the basis of the FSC (size) 
and SSC (complexities) scatter plot; singlets were then selected based on the linear correlation 
between the FSC-area (FSC-A) and the FSC-height (FSC-H); dead cells were excluded by 7-




c57BL/6 blastocysts were injected with Oct4∆Obs ESCs (n=10 cells/embryo), for a total of 50 
embryos and transferred into B6D2F1 foster mothers. Chimerism was assessed by extent of coat 
color mosaicism.  
 
RNA extraction, cDNA synthesis and RT-qPCR experiments  
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Total RNA was extracted from cell lysates using TRIzol® Reagent (Invitrogen) and reverse 
transcribed using Superscript II (Invitrogen) according to the manufacturer’s instructions. First-
strand cDNA was used for RT-qPCR analysis using Power SYBR Green Master Mix (Applied 
Biosystems). RT-qPCR experiments were performed on RNA extracted from about 80 cell 
aggregates per time point (from EpiLC, throughout day 2) for protocols 1, 3-9, using primers 
specific for Otx2, Oct4, Nanog, Ap2γ, Blimp1, T and Hoxb1. RT-qPCR experiments were also 
performed on RNA extracted from SSEA1+-CD61+ cells, FACS-sorted with the same gating 
strategy previously described, at day 6 of PGCLC differentiation using protocols 1 and 9. For 
SSEA1+-CD61+ sorted cells, primers were specific for Blimp1, Prdm14, Ap2γ, Nanos3, Ddx4 (also 
known as Mvh), Prmt5, Fragilis, ALPL (also known as TNAP), Gcna1, DAZL (also known as 
DAZLA), and Kit. Gene expression was normalized to TATA-box Binding Protein (TBP) transcripts 
according to 2(Ct TBP - Ct target) formula. Experiments were performed as biological triplicates and 
technical duplicates. Oligonucleotide sequences for RT-qPCR analysis are listed in Table S5.  
Western blot assay 
Total cell lysates were loaded and run on a 10.5% SDS-PAGE gel. Proteins were transferred onto 
Protran nitrocellulose membranes (GE Healthcare), blocked in 5% skimmed milk (BioRad) for 1 
hour at room temperature, and incubated with primary antibodies (4°C, overnight). PBS plus Tween 
20 washes were carried out before and after secondary antibodies incubation (1 hour at room 
temperature). Protein expression was revealed by ECL reactions (GE Healthcare). Western Blot 
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Fig. 1. Expression analysis during germline differentiation. (A) Representative sections of E6.5, 
E7 and E7.5 embryos stained with the indicated antibody combinations. Yellow arrows, 
differentiating PGCs; white arrows, FRAGILIS+-AP2γ- cells with low or moderate OTX2 levels. 
Note that at E6.5 sections are along a sagittal-oblique plane and at E7 and E7.5 sections are along a 
sagittal plane. Scale bar = 50µm. (B) Protocol 1 experimental design. Cell aggregates were 
analyzed at d0.5, d1 and d2. (C) Immunohistochemistry analysis performed on representative 
sections using the indicated antibody combinations.. Scale bar = 100µm. (A,C) Sections were 
counterstained with Dapi. 
 
Fig. 2. OTX2 binding to Oct4 or Nanog enhancer region regulates PGCLC and somatic 
mesoderm differentiation. (A)  Protocol 1 experimental design. (B,C) FACS analysis performed at 
d6 on wt, ∆Obs and Otx2KO cell aggregates with SSEA1 and CD61 antibodies. (D) Counting at 
d2 of cells expressing the indicated TFs in wt and mutants. Data are the mean ± SD of 3 
independent experiments. P value: *= between 0,005 and 0,001; **=<0,001; and ***=<<0,001. 
(E) Representative immunostainings performed at d2 on sections from wt, ∆Obs and Otx2KO 
cell aggregates using the indicated antibodies. Sections were counterstained with Dapi. Scale 
bar = 100µm. (F,G) RT-qPCR analysis showing the expression profile of Otx2, Oct4, Nanog, Ap2γ, 
Blimp1 and T in EpiLCs and in cell aggregates at d0.25, d0.5, d1 and d2 (F) and Hoxb1 expression 
at d2 (G). Data were normalized to TBP mRNA and reported as the mean ± SD of 3 independent 
experiments. (H) ChIP-qPCR analysis performed at d2 in wt and Oct4∆Obs cell aggregates to 
assess the H3K9me3 enrichment level on the DE and PE of Oct4. Data are the mean ± SD of 3 
independent experiments. (I) Protocol 2 experimental design. (J) FACS analysis at d6 on wt, ∆Obs 
and Otx2KO cell aggregates with SSEA1 and CD61 antibodies. 
 
Fig. 3. Cytokines requirement for PGCLC differentiation in ∆Obs mutants. (A) Protocol 3 
experimental design. (B) FACS analysis for SSEA1 and CD61 at d6 on wt, ∆Obs and Otx2KO 
cell aggregates. (C) Counting at d2 of cells expressing the indicated TFs in wt and mutants. 
Data are the mean ± SD of 3 independent experiments. P value: *=between 0,005 and 0,001; 
**=<0,001; ***=<<0,001. (D,E) RT-qPCR analysis of the indicated transcripts at the time 
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points shown (D), and Hoxb1 expression at d2 (E). Data were normalized to TBP mRNA and 
reported as the mean ± SD of 3 independent experiments. 
 
Fig. 4. In ∆Obs mutants LIF stimulates PGCLC differentiation and suppresses somatic 
fate more efficiently than BMP4. (A) Protocol 4 experimental design. (B) FACS analysis for 
SSEA1 and CD61 at d6 on wt, ∆Obs and Otx2KO cell aggregates. (C) Counting at d2 of cells 
expressing the indicated TFs in wt and mutants. (D,E) RT-qPCR analysis of the indicated 
transcripts at the time points shown (D) and Hoxb1 expression at d2 (E). (F) Protocol 5 
experimental design. (G) FACS analysis for SSEA1 and CD61 at d6 on wt, ∆Obs and Otx2KO 
cell aggregates. (H) Counting at d2 of cells expressing the indicated TFs in wt and mutants. (I,J) 
RT-qPCR analysis of the indicated transcripts at the time points shown (I), and Hoxb1 
expression at d2 (J). (C,H) Data are the mean ± SD of 3 independent experiments. P value: 
*=between 0,005 and 0,001; **=<0,001 and ***=<<0,001. (D,E,I,J) Data were normalized to 
TBP mRNA and reported as the mean ± SD of 3 independent experiments. 
 
Fig. 5. Germline entry of ∆Obs mutants is enhanced by LIF in conjunction with CHIR. (A)  
Protocol 6 experimental design. (B) FACS analysis for SSEA1 and CD61 at d6 on wt, ∆Obs and 
Otx2KO cell aggregates. (C) Counting at d2 of cells expressing the indicated TFs in wt and 
mutants. (D,E) RT-qPCR analysis of the indicated transcripts at the time points shown (D), and 
Hoxb1 expression at d2 (E). (F) Protocol 7 experimental design. (G) FACS analysis for SSEA1 
and CD61 at d6 on wt, ∆Obs and Otx2KO cell aggregates.  (H) Counting at d2 of cells 
expressing the indicated TFs in wt and mutants. (I,J) RT-qPCR analysis of the indicated 
transcripts at the time points shown (I), and Hoxb1 expression at d2 (J). (C,H) Data are the 
mean ± SD of 3 independent experiments. P value: *=between 0,005 and 0,001; **=<0,001 and 
***=<<0,001. (D,E,I,J) Data were normalized to TBP mRNA and reported as the mean ± SD of 
3 independent experiments. 
 
Fig. 6. Germline entry of ∆Obs mutants is markedly increased by LIF in synergism with 
CHIR and low dosage of BMP4, BMP8a, SCF and EGF. (A) Protocol 8 experimental design. 
(B) FACS analysis for SSEA1 and CD61 at d6 on wt, ∆Obs and Otx2KO cell aggregates. (C) 
Counting at d2 of cells expressing the indicated TFs in wt and mutants. (D,E) RT-qPCR 
analysis of the indicated transcripts at the time points shown (D), and Hoxb1 expression at d2 
(E). (F) Protocol 9 experimental design. (G) FACS analysis for SSEA1 and CD61 at d6 on wt, 
∆Obs and Otx2KO cell aggregates. (H) Counting at d2 of cells expressing the indicated TFs in 
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wt and mutants. (I,J) RT-qPCR analysis of the indicated transcripts at the time points shown (I), 
and Hoxb1 expression at d2 (J). (K) ChIP-qPCR analysis performed at d2 in wt and Oct4∆Obs cell 
aggregates to assess the H3K9me3 enrichment level on the DE and PE of Oct4. Data are the mean ± 
SD of 3 independent experiments. (C,H) Data are the mean ± SD of 3 independent experiments. 
P value: *=between 0,005 and 0,001; **=<0,001 and ***=<<0,001. (D,E,I,J) Data were 
normalized to TBP mRNA and reported as the mean ± SD of 3 independent experiments. 
 
Fig. 7. Nuclear translocation of OTX2-ERT2 attenuates without suppressing germline entry 
of Oct4∆Obs and Nanog∆Obs3 cell lines. (A,B) FACS analysis for SSEA1 and CD61 at d6 on 
the indicated mutant cell lines cultured according to protocol 1 with (A) or without (B) Tx from d0 
to d2. (C) Immunohistochemistry experiments performed at d2 on representative sections from Tx-
treated cell lines stained with the indicated antibodies  Note that AP2γ+ PGCLCs co-express high 
NANOG (yellow arrows), SOX2 (white arrows) and high OCT4 (pink arrows) only in 
Nanog∆Obs3;Otx2ERT2 cells. (D) Immunostaining assays showing that OTX2-ERT2 is co-
expressed with BLIMP1 in all cell lines (red arrows). Sections were counterstained with Dapi. 
Scale bar = 100µm. For Oct4∆Obs;Otx2ERT2 and Nanog∆Obs3;Otx2ERT2 mutants, two 
independent clones were analyzed. (E) RT-qPCR analysis performed at d2 to determine the 
expression level of Prdm14 and Blimp1 in all cell lines. Data were normalized to TBP mRNA 
and reported as the mean ± SD of 3 independent experiments. 
 
Fig. 8. Increased generation of PGCs in ∆Obs mutant embryos. (A) Immunohistochemistry 
analysis of wt and ∆Obs homozygous embryos at E6.7 and E7.5 using the indicated antibodies. 
Sections were counterstained with Dapi. Arrow points to PGCs. Scale bar = 50µm. (B) PGC 
counting data collected in wt and ∆Obs embryos at E7.5 and E8.5. The number of PGCs is 
reported as mean ± SD. P value: *= between 0,005 and 0,001; **=<0,001 and ***=<<0,001. 
  
Fig. 9. Model of OTX2 action in germline and somatic mesoderm differentiation. Diagram 
illustrating the role of OTX2 in controlling the contribution of EpiLC-derived cells to germline 
and somatic mesoderm. (A) During the cell aggregation phase, Otx2 suppression by LIF, BMP4 
and WNT generates OTX2+ and OTX2- cell subtypes. OTX2- cells (on the right) activate the 
PGCLC pluripotency GRN and supported by cytokine-dependent stimulation of proliferation enter 
the germline differentiation program to generate PGCLCs in 15% of the population; OTX2+ cells 
(on the left) enter primed pluripotency via OTX2 repression of the PGCLC pluripotency GRN and 
generate somatic mesoderm cells in about 70-80% of the population. (B) In ∆Obs mutants, the 
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initial steps giving rise to the OTX2- and OTX2+ cell subtypes and the germline fate of the OTX2- 
cell subtype (on the right) are apparently unaffected. In contrast, entry into primed pluripotency of 
the OTX2+ cell subtype (on the left) is limited by the inability of OTX2 to repress the pluripotency 
GRN, which together with cytokines promote germline differentiation. This is reflected by a switch 
from somatic into germline fate in both ∆Obs mutants. The distal and proximal transcription 
start sites (TSSs) of Otx2 are indicated. The DE and PE of Oct4 are framed in blue and red, with 
the blue and red horizontal arrows corresponding to Oct4 transcripts driven by the DE and PE, 
respectively. The size of the horizontal arrow in correspondence of the TSS of Nanog and in 
correspondence of the TSSs of Otx2 is proportional to the transcriptional activity. The green 
boxes correspond to Obs2 for Oct4 and to Obs3 for Nanog. 
 
 









